4.6 Review

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer

Journal

MOLECULES
Volume 26, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/molecules26051417

Keywords

Nrf2; Keap1; cancer; oxidative stress

Ask authors/readers for more resources

Cancer is a fatal disease with increasing mortality worldwide, and dysregulation of the NRF2/KEAP1 signaling pathway promotes tumor cell survival and metastasis in various cancers.
Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associated protein 1 (KEAP1) are main players of the cellular defense mechanisms against internal and external cell stressors. However, NRF2/KEAP1 signaling pathway is dysregulated in various cancers, thus promoting tumor cell survival and metastasis. In the present review, we discuss the mechanisms of normal and deregulated NRF2 signaling pathway focusing on its cancer-related functions. We further explore activators and inhibitors of this pathway as cancer targeting drug candidates in order to provide an extensive background on the subject.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available